Factors of occurrence of ocular toxoplasmosis. A review
Parasite, 17 3 (2010) 177-182
Published online: 2010-09-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Influence of killer immunoglobulin-like receptors genes on the recurrence rate of ocular toxoplasmosis in Brazil
Daiana de Souza Perce-da-Silva, Thays Euzebio Joaquim, Ana Luisa Quintella do Couto Aleixo, et al.Memórias do Instituto Oswaldo Cruz 118 (2023)
https://doi.org/10.1590/0074-02760220203
Azithromycin concentration in rabbits’ plasma and posterior segment of the eyes following oral drug administration: a dose-finding study for the application in ocular toxoplasmosis
Hisar Daniel, Melva Louisa and Lukman EdwarJournal of Pharmacy and Pharmacology 74 (12) 1743 (2022)
https://doi.org/10.1093/jpp/rgac059
Macular Infarction Following Intravitreal Clindamycin Injection
Alireza Hedayatfar, Amin Zand, Hooshang Faghihi, Arzhang Gordiz and Fatemeh AbdiJournal of Current Ophthalmology 33 (3) 349 (2021)
https://doi.org/10.4103/joco.joco_150_20
Screening for common eye diseases in the elderly with Optos ultra-wide-field scanning laser ophthalmoscopy: a pilot study with focus on ocular toxoplasmosis
Pablo Eduardo Logroño Wiese, Frank Seeber, Anne-Sophie Endres, Claudia Brockmann and Uwe PleyerInternational Ophthalmology 41 (5) 1573 (2021)
https://doi.org/10.1007/s10792-020-01683-z
Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis
João Paulo Fernandes Felix, Rodrigo Pessoa Cavalcanti Lira, Alex Treiger Grupenmacher, et al.American Journal of Ophthalmology 213 195 (2020)
https://doi.org/10.1016/j.ajo.2019.12.025
(2020)
https://doi.org/10.1101/2020.09.16.299446
Ocular toxoplasmosis associated with up-regulation of miR-155-5p/miR-29c-3p and down-regulation of miR-21-5p/miR-125b-5p
Cristina Silva Meira-Strejevitch, Ingrid de Siqueira Pereira, Daise Damaris Carnietto Hippólito, et al.Cytokine 127 154990 (2020)
https://doi.org/10.1016/j.cyto.2020.154990
Immune Mediator Profile in Aqueous Humor Differs in Patients with Primary Acquired Ocular Toxoplasmosis and Recurrent Acute Ocular Toxoplasmosis
Claudia Thieme, Stephan Schlickeiser, Sylvia Metzner, Claudia Dames and Uwe PleyerMediators of Inflammation 2019 1 (2019)
https://doi.org/10.1155/2019/9356728
Toxoplasmosis in Transplant Recipients, Europe, 2010–2014
Florence Robert-Gangneux, Valeria Meroni, Damien Dupont, et al.Emerging Infectious Diseases 24 (8) 1497 (2018)
https://doi.org/10.3201/eid2408.180045
Intravitreal Clindamycin and Dexamethasone Combined with Systemic Oral Antitoxoplasma Therapy versus Intravitreal Therapy Alone in the Management of Toxoplasma Retinochoroiditis: A Retrospective Study
Ashraf Bor’i, Ashraf Mahrous, Mahmoud A. Al-Aswad, et al.Journal of Ophthalmology 2018 1 (2018)
https://doi.org/10.1155/2018/4160837
Serum levels of neurotrophic factors in active toxoplasmic retinochoroiditis
Cynthia Azeredo Cordeiro, Erica Leandro Marciano Vieira, Natália Pessoa Rocha, et al.The Brazilian Journal of Infectious Diseases 21 (2) 176 (2017)
https://doi.org/10.1016/j.bjid.2016.11.005
Evaluation of gene expression levels for cytokines in ocular toxoplasmosis
M. M. Maia, C. S. Meira‐Strejevitch, V. L. Pereira‐Chioccola, D. D. C. de Hippólito, V. O. Silva, C. C. Brandão de Mattos, F. B. Frederico, R. C. Siqueira and L. C. de MattosParasite Immunology 39 (10) (2017)
https://doi.org/10.1111/pim.12462
The Infected Eye
Andre J. WitkinThe Infected Eye 101 (2016)
https://doi.org/10.1007/978-3-319-42840-6_6
Diagnostic Pathology: Neuropathology
Diagnostic Pathology: Neuropathology 680 (2016)https://doi.org/10.1016/B978-0-323-44592-4.50123-2
Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up
João Paulo Fernandes Felix, Rodrigo Pessoa Cavalcanti Lira, Alexandre Brito Cosimo, et al.American Journal of Ophthalmology 170 176 (2016)
https://doi.org/10.1016/j.ajo.2016.08.003
Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy
Merih Oray, Pinar Cakar Ozdal, Zafer Cebeci, Nur Kir and Ilknur Tugal-TutkunOcular Immunology and Inflammation 24 (6) 637 (2016)
https://doi.org/10.3109/09273948.2015.1057599
Effect ofToxoplasma gondiiinfection on the junctional complex of retinal pigment epithelial cells
ALANDERSON R. NOGUEIRA, FERNANDA LEVE, JOSÉ MORGADO-DIAZ, ROBERTO CARLOS TEDESCO and MIRIAN CLAUDIA S. PEREIRAParasitology 143 (5) 568 (2016)
https://doi.org/10.1017/S0031182015001973
Host and Toxoplasma gondii genetic and non-genetic factors influencing the development of ocular toxoplasmosis: A systematic review
Carolina Fernández, Jesús Jaimes, María Camila Ortiz and Juan David RamírezInfection, Genetics and Evolution 44 199 (2016)
https://doi.org/10.1016/j.meegid.2016.06.053
Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders
Piergiorgio Neri, Ilir Arapi, Uwe Pleyer, et al.Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders 161 (2014)
https://doi.org/10.1007/978-3-642-54350-0_10
Ocular toxoplasmosis past, present and new aspects of an old disease
M. Maenz, D. Schlüter, O. Liesenfeld, et al.Progress in Retinal and Eye Research 39 77 (2014)
https://doi.org/10.1016/j.preteyeres.2013.12.005
Excretory–secretory antigens: A suitable candidate for immunization against ocular toxoplasmosis in a murine model
Kiumars Norouzpour Deilami, Ahmad Daryani, Ehsan Ahmadpour, et al.Comparative Immunology, Microbiology and Infectious Diseases 37 (5-6) 369 (2014)
https://doi.org/10.1016/j.cimid.2014.10.003
Epidemiological and serological profiles of ocular toxoplasmosis in the municipality of Natal, northeastern Brazil
Norma H. D. Mendes, Claudio B. S. Oliveira, Carlos A. Garcia, Cecília M. X. C. Holanda and Valter F. Andrade-NetoTransactions of The Royal Society of Tropical Medicine and Hygiene 108 (10) 656 (2014)
https://doi.org/10.1093/trstmh/tru113
Goldman's Cecil Medicine
Jose G. MontoyaGoldman's Cecil Medicine 2030 (2012)
https://doi.org/10.1016/B978-1-4377-1604-7.00357-2
Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia
D Kovačević-Pavićević, A Radosavljević, A Ilić, I Kovačević and O Djurković-DjakovićEye 26 (5) 723 (2012)
https://doi.org/10.1038/eye.2012.20
Goldman's Cecil Medicine
Jose G. MontoyaGoldman's Cecil Medicine e178 (2012)
https://doi.org/10.1016/B978-1-4377-1604-7.00573-X
Toxoplasmosis: new challenges for an old disease
B Bodaghi, V Touitou, C Fardeau, L Paris and P LeHoangEye 26 (2) 241 (2012)
https://doi.org/10.1038/eye.2011.331
Ocular Parasitoses and Their Immunology
Suggerappa Laxmanappa Hoti and Veena TandonOcular Immunology and Inflammation 19 (6) 385 (2011)
https://doi.org/10.3109/09273948.2011.626141
Phosphodiesterase Inhibitors as a New Generation of Antiprotozoan Drugs: Exploiting the Benefit of Enzymes that are Highly Conserved Between Host and Parasite
Thomas Seebeck, Geert Jan Sterk and Hengming KeFuture Medicinal Chemistry 3 (10) 1289 (2011)
https://doi.org/10.4155/fmc.11.77